1
|
Pascual‐Alonso A, Blasco L, Vidal S, Gean E, Rubio P, O'Callaghan M, Martínez‐Monseny AF, Castells AA, Xiol C, Català V, Brandi N, Pacheco P, Ros C, Campo M, Guillén E, Ibañez S, Sánchez MJ, Lapunzina P, Nevado J, Santos F, Lloveras E, Ortigoza‐Escobar JD, Tejada MI, Maortua H, Martínez F, Orellana C, Roselló M, Mesas MA, Obón M, Plaja A, Fernández‐Ramos JA, Tizzano E, Marín R, Peña‐Segura JL, Alcántara S, Armstrong J. Front Cover. Clin Genet 2020. [DOI: 10.1111/cge.13733] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
| | - Laura Blasco
- Fundación San Juan de DiosServicio de Medicina Genética y Molecular Barcelona Spain
| | - Silvia Vidal
- Fundación San Juan de DiosServicio de Medicina Genética y Molecular Barcelona Spain
| | - Esther Gean
- Departamento de Medicina Genética y MolecularHospital Universitario San Juan de Dios Barcelona Spain
| | - Patricia Rubio
- Departamento de Medicina Genética y MolecularHospital Universitario San Juan de Dios Barcelona Spain
| | - Mar O'Callaghan
- Departamento de Neurología PediátricaHospital Universitario San Juan de Dios Barcelona Spain
| | | | - Alba Aina Castells
- Fundación San Juan de DiosServicio de Medicina Genética y Molecular Barcelona Spain
- Neural Development Lab, Departament de Patologia i Terapèutica Experimental, Institut de NeurociènciesUniversitat de Barcelona, IDIBELL, l'Hospitalet de Llobregat Barcelona Spain
| | - Clara Xiol
- Fundación San Juan de DiosServicio de Medicina Genética y Molecular Barcelona Spain
| | - Vicenç Català
- Unitad de Biología Celular y Genética Médica, Departament of BCFyIUniversidad Autónoma de Barcelona Barcelona Spain
| | - Nuria Brandi
- Servicio de Medicina Genètica i MolecularHospital Universitario San Juan de Dios Barcelona Spain
| | - Paola Pacheco
- Servicio de Medicina Genètica i MolecularHospital Universitario San Juan de Dios Barcelona Spain
| | - Carlota Ros
- Servicio de Medicina Genètica i MolecularHospital Universitario San Juan de Dios Barcelona Spain
| | - Miguel Campo
- Pediatrics, Genetic EpidemiologyHospital Valle Hebrón Barcelona Spain
| | - Encarna Guillén
- Unidad de GenéticaHospital Virgen de la Arrixaca Murcia Spain
| | - Salva Ibañez
- Unidad de GenéticaHospital Virgen de la Arrixaca Murcia Spain
| | | | - Pablo Lapunzina
- Instituto de Genética Médica y MolecularHospital Universitario La Paz Madrid Spain
- CIBERER (Biomedical Network Research Center for Rare Diseases)Instituto de Salud Carlos III Madrid Spain
| | - Julián Nevado
- Instituto de Genética Médica y MolecularHospital Universitario La Paz Madrid Spain
- CIBERER (Biomedical Network Research Center for Rare Diseases)Instituto de Salud Carlos III Madrid Spain
| | - Fernando Santos
- Instituto de Genética Médica y MolecularHospital Universitario La Paz Madrid Spain
| | | | | | - María I. Tejada
- CIBERER (Biomedical Network Research Center for Rare Diseases)Instituto de Salud Carlos III Madrid Spain
- Laboratorio de Genética Molecular, Servicio de Genética, Instituto de Investigación Sanitaria BiocrucesHospital Universitario de Cruces Barakaldo Spain
| | - Hiart Maortua
- CIBERER (Biomedical Network Research Center for Rare Diseases)Instituto de Salud Carlos III Madrid Spain
- Laboratorio de Genética Molecular, Servicio de Genética, Instituto de Investigación Sanitaria BiocrucesHospital Universitario de Cruces Barakaldo Spain
| | - Francisco Martínez
- Unidad de GenéticaHospital Universitario y Politécnico La Fe Valencia Spain
| | - Carmen Orellana
- Unidad de GenéticaHospital Universitario y Politécnico La Fe Valencia Spain
| | - Mónica Roselló
- Unidad de GenéticaHospital Universitario y Politécnico La Fe Valencia Spain
| | | | - María Obón
- Area de Genètica Clínica i Consell GenèticLaboratoris ICS Girona Spain
| | - Alberto Plaja
- Institut de Recerca (VHIR), Universitat Autònoma de BarcelonaHospital Universitari Vall d'Hebron Barcelona Spain
| | | | - Eduardo Tizzano
- Area Genética Clínica y MolecularHospital Universitari Vall d'Hebron Barcelona Spain
| | - Rosario Marín
- Hospital Universitario Puerta del Mar Unidad de Genética Cádiz Spain
| | | | - Soledad Alcántara
- Neural Development Lab, Departament de Patologia i Terapèutica Experimental, Institut de NeurociènciesUniversitat de Barcelona, IDIBELL, l'Hospitalet de Llobregat Barcelona Spain
| | - Judith Armstrong
- Servicio de Medicina Genètica i MolecularHospital Universitario San Juan de Dios Barcelona Spain
- CIBERER (Biomedical Network Research Center for Rare Diseases)Instituto de Salud Carlos III Madrid Spain
- Institut de Recerca PediàtricaHospital Sant Joan de Déu Barcelona Spain
| |
Collapse
|
2
|
Pascual-Alonso A, Blasco L, Vidal S, Gean E, Rubio P, O'Callaghan M, Martínez-Monseny AF, Castells AA, Xiol C, Català V, Brandi N, Pacheco P, Ros C, Del Campo M, Guillén E, Ibañez S, Sánchez MJ, Lapunzina P, Nevado J, Santos F, Lloveras E, Ortigoza-Escobar JD, Tejada MI, Maortua H, Martínez F, Orellana C, Roselló M, Mesas MA, Obón M, Plaja A, Fernández-Ramos JA, Tizzano E, Marín R, Peña-Segura JL, Alcántara S, Armstrong J. Molecular characterization of Spanish patients with MECP2 duplication syndrome. Clin Genet 2020; 97:610-620. [PMID: 32043567 DOI: 10.1111/cge.13718] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2019] [Revised: 02/04/2020] [Accepted: 02/05/2020] [Indexed: 12/16/2022]
Abstract
MECP2 duplication syndrome (MDS) is an X-linked neurodevelopmental disorder characterized by a severe to profound intellectual disability, early onset hypotonia and diverse psycho-motor and behavioural features. To date, fewer than 200 cases have been published. We report the clinical and molecular characterization of a Spanish MDS cohort that included 19 boys and 2 girls. Clinical suspicions were confirmed by array comparative genomic hybridization and multiplex ligation-dependent probe amplification (MLPA). Using, a custom in-house MLPA assay, we performed a thorough study of the minimal duplicated region, from which we concluded a complete duplication of both MECP2 and IRAK1 was necessary for a correct MDS diagnosis, as patients with partial MECP2 duplications lacked some typical clinical traits present in other MDS patients. In addition, the duplication location may be related to phenotypic severity. This observation may provide a new approach for genotype-phenotype correlations, and thus more personalized genetic counselling.
Collapse
Affiliation(s)
- Ainhoa Pascual-Alonso
- Fundación San Juan de Dios, Servicio de Medicina Genética y Molecular, Barcelona, Spain
| | - Laura Blasco
- Fundación San Juan de Dios, Servicio de Medicina Genética y Molecular, Barcelona, Spain
| | - Silvia Vidal
- Fundación San Juan de Dios, Servicio de Medicina Genética y Molecular, Barcelona, Spain
| | - Esther Gean
- Departamento de Medicina Genética y Molecular, Hospital Universitario San Juan de Dios, Barcelona, Spain
| | - Patricia Rubio
- Departamento de Medicina Genética y Molecular, Hospital Universitario San Juan de Dios, Barcelona, Spain
| | - Mar O'Callaghan
- Departamento de Neurología Pediátrica, Hospital Universitario San Juan de Dios, Barcelona, Spain
| | - Antonio F Martínez-Monseny
- Departamento de Medicina Genética y Molecular, Hospital Universitario San Juan de Dios, Barcelona, Spain
| | - Alba Aina Castells
- Fundación San Juan de Dios, Servicio de Medicina Genética y Molecular, Barcelona, Spain.,Neural Development Lab, Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, IDIBELL, l'Hospitalet de Llobregat, Barcelona, Spain
| | - Clara Xiol
- Fundación San Juan de Dios, Servicio de Medicina Genética y Molecular, Barcelona, Spain
| | - Vicenç Català
- Unitad de Biología Celular y Genética Médica, Departament of BCFyI, Universidad Autónoma de Barcelona, Barcelona, Spain
| | - Nuria Brandi
- Servicio de Medicina Genètica i Molecular, Hospital Universitario San Juan de Dios, Barcelona, Spain
| | - Paola Pacheco
- Servicio de Medicina Genètica i Molecular, Hospital Universitario San Juan de Dios, Barcelona, Spain
| | - Carlota Ros
- Servicio de Medicina Genètica i Molecular, Hospital Universitario San Juan de Dios, Barcelona, Spain
| | - Miguel Del Campo
- Pediatrics, Genetic Epidemiology, Hospital Valle Hebrón, Barcelona, Spain
| | - Encarna Guillén
- Unidad de Genética, Hospital Virgen de la Arrixaca, Murcia, Spain
| | - Salva Ibañez
- Unidad de Genética, Hospital Virgen de la Arrixaca, Murcia, Spain
| | - María J Sánchez
- Unidad de Genética, Hospital Virgen de la Arrixaca, Murcia, Spain
| | - Pablo Lapunzina
- Instituto de Genética Médica y Molecular, Hospital Universitario La Paz, Madrid, Spain.,CIBERER (Biomedical Network Research Center for Rare Diseases), Instituto de Salud Carlos III, Madrid, Spain
| | - Julián Nevado
- Instituto de Genética Médica y Molecular, Hospital Universitario La Paz, Madrid, Spain.,CIBERER (Biomedical Network Research Center for Rare Diseases), Instituto de Salud Carlos III, Madrid, Spain
| | - Fernando Santos
- Instituto de Genética Médica y Molecular, Hospital Universitario La Paz, Madrid, Spain
| | | | - Juan D Ortigoza-Escobar
- Departamento de Neurología Pediátrica, Hospital Universitario San Juan de Dios, Barcelona, Spain
| | - María I Tejada
- CIBERER (Biomedical Network Research Center for Rare Diseases), Instituto de Salud Carlos III, Madrid, Spain.,Laboratorio de Genética Molecular, Servicio de Genética, Instituto de Investigación Sanitaria Biocruces, Hospital Universitario de Cruces, Barakaldo, Spain
| | - Hiart Maortua
- CIBERER (Biomedical Network Research Center for Rare Diseases), Instituto de Salud Carlos III, Madrid, Spain.,Laboratorio de Genética Molecular, Servicio de Genética, Instituto de Investigación Sanitaria Biocruces, Hospital Universitario de Cruces, Barakaldo, Spain
| | - Francisco Martínez
- Unidad de Genética, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Carmen Orellana
- Unidad de Genética, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Mónica Roselló
- Unidad de Genética, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | | | - María Obón
- Area de Genètica Clínica i Consell Genètic, Laboratoris ICS, Girona, Spain
| | - Alberto Plaja
- Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | | | - Eduardo Tizzano
- Area Genética Clínica y Molecular, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - Rosario Marín
- Hospital Universitario Puerta del Mar Unidad de Genética, Cádiz, Spain
| | - José L Peña-Segura
- Unidad de Neuropediatría, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - Soledad Alcántara
- Neural Development Lab, Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, IDIBELL, l'Hospitalet de Llobregat, Barcelona, Spain
| | - Judith Armstrong
- Servicio de Medicina Genètica i Molecular, Hospital Universitario San Juan de Dios, Barcelona, Spain.,CIBERER (Biomedical Network Research Center for Rare Diseases), Instituto de Salud Carlos III, Madrid, Spain.,Institut de Recerca Pediàtrica, Hospital Sant Joan de Déu, Barcelona, Spain
| |
Collapse
|
3
|
Rigola MA, Baena N, Català V, Lozano I, Gabau E, Guitart M, Fuster C. A 11.7-Mb Paracentric Inversion in Chromosome 1q Detected in Prenatal Diagnosis Associated with Familial Intellectual Disability. Cytogenet Genome Res 2015; 146:109-114. [PMID: 26280689 DOI: 10.1159/000437127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/02/2015] [Indexed: 11/19/2022] Open
Abstract
Most apparent balanced chromosomal inversions are usually clinically asymptomatic; however, infertility, miscarriages, and mental retardation have been reported in inversion carriers. We present a small family with a paracentric inversion 1q42.13q43 detected in routine prenatal diagnosis. Molecular cytogenetic methods defined the size of the inversion as 11.7 Mb and excluded other unbalanced chromosomal alterations in the patients. Our findings suggest that intellectual disability is caused by dysfunction, disruption, or position effects of genes located at or near the breakpoints involved in this inversion.
Collapse
Affiliation(s)
- Maria A Rigola
- Unitat de Biologia Cel∙lular i Genètica Mèdica, Departament de Biologia Cel∙lular, Fisiologia i Immunologia, Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
| | | | | | | | | | | | | |
Collapse
|
4
|
Plaja A, Lloveras E, Martinez-Bouzas C, Barreña B, Del Campo M, Fernández A, Herrero M, Barranco L, Palau N, López-Aríztegui MA, Català V, Tejada MI. Trisomy 18p caused by a supernumerary marker with a chromosome 13/21 centromere: a possible recurrent chromosome aberration. Am J Med Genet A 2013; 161A:2363-8. [PMID: 23894094 DOI: 10.1002/ajmg.a.36102] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2012] [Accepted: 05/27/2013] [Indexed: 11/08/2022]
Abstract
We present a clinical and molecular cytogenetic characterization of two new patients with a complex supernumerary marker consisting of the entire short arm of chromosome 18 with a chromosome 13/21 centromere. One patient is a girl with a nonsyndromic intellectual disability and the second is a prenatally diagnosed fetus. To our knowledge, these are the fourth and fifth such cases to be described in the literature, suggesting the existence of a possible recurring constitutional structural chromosome abnormality.
Collapse
Affiliation(s)
- Alberto Plaja
- Citogenética, General Lab-Laboratoris d'Anàlisis, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Lloveras E, Canellas A, Cirigliano V, Català V, Cerdan C, Plaja A. Supernumerary ring chromosome: an etiology for Pallister-Killian syndrome? Fetal Diagn Ther 2013; 34:172-5. [PMID: 23485930 DOI: 10.1159/000347049] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2012] [Accepted: 12/29/2012] [Indexed: 11/19/2022]
Abstract
Characterization of marker chromosomes before the introduction of array CGH (aCGH) assays was only based on their banding patterns (G, C, and NOR staining) and fluorescent in situ hybridization techniques. The use of aCGH greatly improves the identification of marker chromosomes in some cases. We describe an atypical case of Pallister-Killian syndrome (PKS) detected at prenatal diagnosis with a very unusual cytogenetic presentation: a supernumerary ring chromosome including two copies of 12p. A similar anomaly described in a postnatal patient suggests ring chromosome as a possible cause of PKS. Extra ring chromosomes might be a more common etiology for PKS than previously thought, given the difficulty in their characterization before the advent of aCGH.
Collapse
Affiliation(s)
- E Lloveras
- Departament de Citogenètica, LABCO-Iberia, Barcelona, Spain
| | | | | | | | | | | |
Collapse
|
6
|
Garcia-Quevedo L, Blanco J, Sarrate Z, Català V, Bassas L, Vidal F. Hidden mosaicism in patients with Klinefelter's syndrome: implications for genetic reproductive counselling. Hum Reprod 2011; 26:3486-93. [PMID: 22016414 DOI: 10.1093/humrep/der351] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023] Open
Abstract
BACKGROUND Most individuals with Klinefelter's syndrome (KS) are azoospermic but residual foci of spermatogenesis have been observed in some patients. However, no consistent predictive factors for testicular sperm extraction success have been established and mosaicism could be a factor to investigate. In this study, we have assessed the degree of mosaicism in somatic and germinal tissues in KS, the meiotic competence of 47,XXY germ cells and the aneuploidy rate of post-reductional cells. METHODS Five patients with KS previously diagnosed as pure 47,XXY have been studied. Samples from four donors were processed as controls. The chromosome constitution of lymphocytes, buccal mucosa and testicular tissue was assessed by interphase fluorescence in situ hybridization for chromosomes X, Y and 18. In meiotic figures, sex chromosome number and pairing was confirmed. RESULTS 46,XY cell lines were observed in all patients and tissues analysed. The degree of mosaicism (mean ± SD) differed among tissues (lowest in lymphocytes: 4.8 ± 2.5%; highest in Sertoli cells: 42.3 ± 11.1%). Meiotic figures were found in three cases (KS1, KS2 and KS5), all of them showed an XY complement. Hyperhaploid post-reductional cells were found in all patients (range: 3.3-36.4%) and increased rates versus controls (P< 0.05) were observed. CONCLUSIONS Diagnosis of homogeneous KS based on lymphocyte karyotyping should be contrasted in other tissues. Mucosa cells could help to better approximate the degree of germ cell mosaicism. Our results indicate that 47,XXY germ cells are not meiotically competent. Increased post-reductional aneuploidy rate is related to meiotic errors in 46,XY cells. Appropriate genetic counselling is recommended in KS.
Collapse
Affiliation(s)
- L Garcia-Quevedo
- Unitat de Biologia Cel·lular, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain
| | | | | | | | | | | |
Collapse
|
7
|
Mayo S, Monfort S, Roselló M, Orellana C, Oltra S, Armstrong J, Català V, Martínez F. De novo Interstitial Triplication of MECP2 in a Girl with Neurodevelopmental Disorder and Random X Chromosome Inactivation. Cytogenet Genome Res 2011; 135:93-101. [DOI: 10.1159/000330917] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/29/2011] [Indexed: 01/08/2023] Open
|
8
|
Morales C, Cuatrecasas E, Mademont-Soler I, Clusellas N, Peruga E, Català V, Garrido C, Milà M, Soler A, Sánchez A. Non-mosaic trisomy 20 of paternal origin in chorionic villus and amniotic fluid also detected in fetal blood and other tissues. Eur J Med Genet 2010; 53:197-200. [PMID: 20350623 DOI: 10.1016/j.ejmg.2010.03.007] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2009] [Accepted: 03/19/2010] [Indexed: 11/18/2022]
Abstract
Trisomy 20 mosaicism is a common abnormality found in prenatal diagnosis. Its clinical significance remains unclear since approximately 90-93% of cases result in normal phenotype. Only 5 cases of non-mosaic trisomy 20 in amniotic fluid culture surviving beyond the first trimester have been reported. Moreover, trisomic cells are generally not detectable in blood and have only been reported in three cases. We present a case of non-mosaic trisomy 20 found in chorionic villi sample and amniotic fluid culture in a fetus with minor abnormalities not detected by ultrasound examination. Pathological examination of the fetus only revealed right pulmonary isomerism and camptodactily, and no major malformations were disclosed. Trisomic lineage was also detected in fetal blood, kidney, skin and brain tissue cultures. Molecular analysis revealed that the extra chromosome 20 was originated in paternal meiosis. To our knowledge, we report the first prenatal case of non-mosaic trisomy 20 of paternal origin that has been confirmed in several fetal tissues, including blood, in a fetus with minor malformations not detected prenatally.
Collapse
Affiliation(s)
- Carme Morales
- Servei de Bioquímica i Genètica Molecular, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain; CIBER de Enfermedades Raras (CIBERER), Barcelona, Spain.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Armstrong J, Póo P, Pineda M, Aibar E, Geán E, Català V, Monrós E. News and comment. Ann Neurol 2001; 50:696. [PMID: 11857656] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
|
10
|
Plaja A, Vendrell T, Smeets D, Sarret E, Gili T, Català V, Mediano C, Scheres JM. Variegated aneuploidy related to premature centromere division (PCD) is expressed in vivo and is a cancer-prone disease. Am J Med Genet 2001; 98:216-23. [PMID: 11169558 DOI: 10.1002/1096-8628(20010122)98:3<216::aid-ajmg1091>3.0.co;2-0] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
We present three patients with variegated aneuploidy and premature centromere division (PCD), a rare chromosomal abnormality in humans. Comparison of these three and eight other patients with variegated aneuploidy related to PCD demonstrates a phenotype comprising most frequently microcephaly, CNS anomalies (with cerebellar affection and migration defects), mental retardation, pre-and postnatal growth retardation, flat and broad nasal bridge, apparently low-set ears, eye and skin abnormalities, and ambiguous genitalia in male patients. The occurrence of Wilms tumor in three patients, rhabdomyosarcoma in two others and acute leukemia in a fifth characterizes this condition as a chromosome or genome instability disorder with a high risk of malignancy. FISH studies in uncultured blood and buccal smear cells demonstrate that the random aneuploidies are not limited to cultured cells, but also occur in vivo.
Collapse
Affiliation(s)
- A Plaja
- Unitat de Genètica, H. Materno-Infantil Vall d'Hebron, Barcelona, Spain.
| | | | | | | | | | | | | | | |
Collapse
|
11
|
Vidal F, Fugger EF, Blanco J, Keyvanfar K, Català V, Norton M, Hazelrigg WB, Black SH, Levinson G, Egozcue J, Schulman JD. Efficiency of MicroSort flow cytometry for producing sperm populations enriched in X- or Y-chromosome haplotypes: a blind trial assessed by double and triple colour fluorescent in-situ hybridization. Hum Reprod 1998; 13:308-12. [PMID: 9557828 DOI: 10.1093/humrep/13.2.308] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Using fluorescent in-situ hybridization (FISH) we have evaluated, on a blind basis, the efficiency of flow cytometry to separate human X- and Y-chromosome bearing spermatozoa. Our data demonstrate that human spermatozoa can be sorted to a purity of 80-90% for X spermatozoa and of 60-70% for Y spermatozoa. Our results using triple FISH fully agree with the sorting treatment used in each case and corroborate the efficiency of the flow sorting technique for sperm sex selection. In these limited samples (200-500 sperm/donor), the frequencies of disomic or diploid spermatozoa were not increased when comparing the sorted samples with unselected samples or with our control series.
Collapse
Affiliation(s)
- F Vidal
- Unitat de Biologia Cellular, Facultat de Ciències, Universitat Autònoma, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Vidal F, Moragas M, Català V, Torelló MJ, Santaló J, Calderón G, Gimenez C, Barri PN, Egozcue J, Veiga A. Sephadex filtration and human serum albumin gradients do not select spermatozoa by sex chromosome: a fluorescent in-situ hybridization study. Hum Reprod 1993; 8:1740-3. [PMID: 7507937 DOI: 10.1093/oxfordjournals.humrep.a137926] [Citation(s) in RCA: 58] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
Fluorescent in-situ hybridization (FISH) of decondensed sperm nuclei has been used directly to evaluate the enrichment efficiency of human sperm separation using Sephadex gel filtration and human serum albumin (HSA) gradients. Control and processed spermatozoa were fixed and their nuclei decondensed. In-situ hybridization was carried out with a Y-specific DNA probe (DYZ1). Sephadex filtration yielded 52.5% Y-chromosome-bearing spermatozoa, HSA separation resulted in 49.4% Y-chromosome-bearing spermatozoa and in the untreated control sample the percentage of Y spermatozoa was 49.3%. Statistical analysis revealed no significant differences between the selection methods employed and the controls, and no real enrichment for X- or Y-bearing spermatozoa was detected for any of the selection methods assayed. The usefulness of the protocols reported for selection of spermatozoa by sex chromosome in couples at risk for X-linked diseases is discussed.
Collapse
Affiliation(s)
- F Vidal
- Departament Biologia Cellular i Fisiologia, Universitat Autònoma de Barcelona, Bellaterra, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Santaló J, Badenas J, Calafell JM, Català V, Munné S, Egozcue J, Estop AM. The genetic risks of in vitro fertilization techniques: the use of an animal model. J Assist Reprod Genet 1992; 9:462-74. [PMID: 1482842 DOI: 10.1007/bf01204053] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
PURPOSE The influence of some technical and biological parameters on the genetic characteristics of embryos derived from in vitro fertilization (IVF) techniques was studied. METHOD Using a murine model, we assessed the effect of gamete manipulation, gamete maturation stage, and maternal age on the chromosome complements of first-cleavage embryos. RESULTS AND CONCLUSIONS We found a positive correlation between some of these parameters and the incidence of the different chromosome abnormalities studied. Regarding aneuploidy, we observed an influence of maternal age, using both prepubertal and old females. Polyspermy showed a positive correlation with in vitro fertilization, the immaturity and overmaturity of the oocytes employed, and the use of prepubertal females. The appearance of diploid female complements was related to oocyte immaturity and prepubertal females, while diploid male complements were directly related to in vitro fertilization. Premature chromosome condensation (PCC) had a direct relationship with oocyte immaturity and in vitro maturation of the oocyte. Finally, structural abnormalities were associated with the process of sperm aging in vitro.
Collapse
Affiliation(s)
- J Santaló
- Departament de Biologia Cellular i Fisiologia, Universitat Autonoma de Barcelona, Bellaterra, Spain
| | | | | | | | | | | | | |
Collapse
|
14
|
Abstract
The use of human material does not allow the determination of the influence of different parameters on the genetic characteristics of the embryos derived from in-vitro fertilization (IVF) techniques. Using a murine model we assessed the effect of gamete manipulation, maternal age and oocyte ageing on the chromosome complements of the embryos. We have found a positive correlation between all these parameters and the incidence of chromosome abnormalities in first-cleavage mouse embryos obtained by IVF.
Collapse
Affiliation(s)
- J Santaló
- Departament de Biologia Cellular i Fisiologia, Faculta de Ciències, Universitat Autònoma de Barcelona, Spain
| | | | | | | |
Collapse
|